INVO Fertility, Inc. Business Acquisition, Pro Forma Revenue
INVO Fertility, Inc. (IVF) reported Business Acquisition, Pro Forma Revenue of $6.56 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-30.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2025-04-30
- INVO Fertility, Inc. business acquisition, pro forma revenue for the quarter ending 2023-12-31 was -$1.83M, a 229.64% decline year-over-year.
- INVO Fertility, Inc. business acquisition, pro forma revenue for the quarter ending 2023-09-30 was $1.49M, a 2.70% decline year-over-year.
- INVO Fertility, Inc. business acquisition, pro forma revenue for the quarter ending 2022-12-31 was $1.41M.
- INVO Fertility, Inc. business acquisition, pro forma revenue for the quarter ending 2022-09-30 was $1.53M.
- INVO Fertility, Inc. business acquisition, pro forma revenue for fiscal 2024 was $6.56M, a 117.21% increase from fiscal 2023.
- INVO Fertility, Inc. business acquisition, pro forma revenue for fiscal 2023 was $3.02M, a 51.30% decline from fiscal 2022.
- INVO Fertility, Inc. business acquisition, pro forma revenue for fiscal 2022 was $6.20M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month | Business Acquisition, Pro Forma Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $6.56M 10-K · filed 2025-04-30 | ||||
| 2023-12-31 | -$1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | -$333.32K derived: sum of 2 quarters · filed 2025-04-30 | $3.02M 10-K · filed 2025-04-30 | $6.23M 10-K · filed 2024-04-16 | |
| 2023-09-30 | $1.49M 10-Q · filed 2023-11-13 | $4.85M 10-Q · filed 2023-11-13 | |||
| 2022-12-31 | $1.41M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-19 | $2.94M derived: sum of 2 quarters · filed 2024-11-19 | $6.20M 10-K/A · filed 2024-11-19 | ||
| 2022-09-30 | $1.53M 10-Q · filed 2023-11-13 | $4.79M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |